PD50 - PD50: Bladder Cancer: Epidemiology & Evaluation II

Podium Presenter(s)

• 

  Ahmed Aly Hussein Aly, MSC

  Roswell Park Comprehensive Cancer Center

  PDF Slides and Audio
• 

  Aeen Asghar, MD

  Temple University

  PDF Slides and Audio
• 

  Marc Bjurlin, DO

  University of North Carolina at Chapel Hill
• JC

  Joshua Caldwell
• 

  Ankur Choksi

  University of Maryland School of Medicine

  PDF Slides and Audio
• MD

  Mohammad Durrani, BS

  Roswell Park Comprehensive Cancer Center

  PDF Slides and Audio
• 

  Teruo Inamoto, MD, PhD

  Osaka Medical College
• PK

  Preston Kerr, MD

  University of Texsas Medical Branch Galveston

  PDF Slides and Audio
• 

  Diana Magee, MD,MPH

  University of Toronto

  PDF Slides
• KM

  KEITA Minami
• MR

  Michael Rezaee, MD

  Dartmouth-Hitchcock Medical Center
• 

  Wei Tian, MD

  VP, Medical Director, Urologic Pathology

  PDF Slides and Audio

Presentations:

• 7:00 AM – 9:00 AM

  PD50-01: Impact of Weekly Multidisciplinary Team Meeting in Implementing Pathways on Early Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Matched Analysis
  Mohammad Durrani, BS
• 7:00 AM – 9:00 AM

  PD50-02: Urine Cytology Diagnostic Patterns Before and After Implementing The Paris System for Reporting Urine Cytology: A Large Single Institutional Study of More Than 27,000 Cases
  Wei Tian, MD – INFORM DIAGNOSTICS
• 7:00 AM – 9:00 AM

  PD50-03: Pattern of expression and mutation status of FGFR2/3 and Nectin-4 in urothelial carcinoma
  Teruo Inamoto, MD, PhD
• 7:00 AM – 9:00 AM

  PD50-04: Urinary extracellular vesicle RNA biomarkers for high-risk non-muscle invasive bladder cancer
  KEITA Minami
• 7:00 AM – 9:00 AM

  PD50-05: Carcinogen Biomarkers in the Urine of Electronic-Cigarette Users and Implications for Potential Bladder Cancer: A Systematic Review
  Marc A. Bjurlin, DO
• 7:00 AM – 9:00 AM

  PD50-06: Proximity to Oil Refineries and Risk of Cancer: A Population-Based Analysis
  Preston Kerr, MD
• 7:00 AM – 9:00 AM

  PD50-07: Systematic Endoscopic Evaluation Falls Short in Predicting pT0 Bladder Cancer: A Prospective Trial
  Aeen M. Asghar, MD
• 7:00 AM – 9:00 AM

  PD50-08: The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC)
  Michael Rezaee, MD
• 7:00 AM – 9:00 AM

  PD50-09: Detailed Analysis of Urinary Tract Infections after Robot-Assisted Radical Cystectomy
  Ahmed Aly Hussein Aly, MSC
• 7:00 AM – 9:00 AM

  PD50-10: 5-&[alpha] Reductase Inhibitors and Risk of Overall and Fatal Bladder Cancer
  Joshua Caldwell
• 7:00 AM – 9:00 AM

  PD50-11: Trimodal Therapy versus Radical Cystectomy for Muscle Invasive Bladder Cancer - A Markov Microsimulation Model
  Diana Magee, MD,MPH
• 7:00 AM – 9:00 AM

  PD50-12: Race as a Predictor of Pathologic Response to Neoadjuvant Chemotherapy at Time of Cystectomy for Bladder Cancer
  Ankur Ushir Choksi